236 related articles for article (PubMed ID: 8655242)
1. Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion.
Packman AM; Brown RH; Dunlap FE; Kraus SJ; Webster GF
Int J Dermatol; 1996 Mar; 35(3):209-11. PubMed ID: 8655242
[No Abstract] [Full Text] [Related]
2. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations.
Lookingbill DP; Chalker DK; Lindholm JS; Katz HI; Kempers SE; Huerter CJ; Swinehart JM; Schelling DJ; Klauda HC
J Am Acad Dermatol; 1997 Oct; 37(4):590-5. PubMed ID: 9344199
[TBL] [Abstract][Full Text] [Related]
3. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
Abeck D
MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325
[No Abstract] [Full Text] [Related]
4. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
Kellett N; West F; Finlay AY
Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
[TBL] [Abstract][Full Text] [Related]
5. New drug information. Acanya.
JAAPA; 2009 Apr; 22(4):12. PubMed ID: 19452815
[No Abstract] [Full Text] [Related]
6. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
Bowman S; Gold M; Nasir A; Vamvakias G
J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and tolerability of a fixed combination clindamycin (1.2%) and benzoyl peroxide (3.75%) aqueous gel in patients with facial acne vulgaris: gender as a clinically relevant outcome variable.
Harper JC
J Drugs Dermatol; 2015 Apr; 14(4):381-4. PubMed ID: 25844612
[TBL] [Abstract][Full Text] [Related]
8. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
Dutil M
Skin Therapy Lett; 2010; 15(10):5-7. PubMed ID: 21076800
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris.
Touitou E; Godin B; Shumilov M; Bishouty N; Ainbinder D; Shouval R; Ingber A; Leibovici V
J Eur Acad Dermatol Venereol; 2008 May; 22(5):629-31. PubMed ID: 18410627
[No Abstract] [Full Text] [Related]
10. A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face.
Gupta AK; Lynde CW; Kunynetz RA; Amin S; Choi K; Goldstein E
J Cutan Med Surg; 2003; 7(1):31-7. PubMed ID: 12362264
[TBL] [Abstract][Full Text] [Related]
11. Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
Bikowski J; Callender VD; Del Rosso JQ; Draelos ZD; Tanghetti E
Cutis; 2006 Aug; 78(2 Suppl 1):13-20. PubMed ID: 17966495
[TBL] [Abstract][Full Text] [Related]
12. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Draelos ZD; Potts A; Alió Saenz AB;
Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
[TBL] [Abstract][Full Text] [Related]
13. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris.
Tschen EH; Katz HI; Jones TM; Monroe EW; Kraus SJ; Connolly MA; Levy SF
Cutis; 2001 Feb; 67(2):165-9. PubMed ID: 11236229
[TBL] [Abstract][Full Text] [Related]
14. Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel.
Harper JC
J Drugs Dermatol; 2012 Dec; 11(12):1440-5. PubMed ID: 23377514
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product.
Leyden JJ; Hickman JG; Jarratt MT; Stewart DM; Levy SF
J Cutan Med Surg; 2001; 5(1):37-42. PubMed ID: 11281433
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Cunliffe WJ; Holland KT; Bojar R; Levy SF
Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
[TBL] [Abstract][Full Text] [Related]
17. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
[TBL] [Abstract][Full Text] [Related]
18. The BEST study: results according to prior treatment.
Rodriguez D; Davis MW
Cutis; 2003 Feb; 71(2 Suppl):27-34. PubMed ID: 12630672
[TBL] [Abstract][Full Text] [Related]
19. The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris.
Chu A; Huber FJ; Plott RT
Br J Dermatol; 1997 Feb; 136(2):235-8. PubMed ID: 9068739
[TBL] [Abstract][Full Text] [Related]
20. Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris.
Tucker SB; Tausend R; Cochran R; Flannigan SA
Br J Dermatol; 1984 Apr; 110(4):487-92. PubMed ID: 6231942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
